Sangamo Biosciences, Inc. (SGMO) Posts Q2 EPS Loss of $0.20, Releases FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
BBGI, COHR, LVWD, More
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
BBGI, COHR, LVWD, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.65 million.
Sangamo Biosciences, Inc. sees FY2011 revenue of $10-$12 million, versus the consensus of $11.03 million.
Sangamo Biosciences, Inc. sees FY2011 revenue of $10-$12 million, versus the consensus of $11.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stem, Inc. (STEM) Tops Q2 EPS by 21c; Offers Guidance
- Fossil Group (FOSL) Tops Q2 EPS by 9c; offers outlook
- Coherent, Inc. (COHR) Tops Q4 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
